Vanessa McDonald

This week is the official commencement of our new Centre of Excellence in Treatable Traits! To kick off we have launched our twitter acc. & logo. We are really excited to generate #treatabletraits knowledge, collaborate, translate and train the next generation. Follow us 4 more!

Bronchoscopy & Pleural Workshop underway for ⁦@tsanz_thoracic⁩ 2024 Hub. ⁦Thx to facilitators: @vin_george2⁩ ⁦@JeevanGERRARD10⁩ Dan Steinfort +Tracy Leong +Lou Irving and the Northern Hosp pleural team ⁦@NCARD_research⁩ ⁦@uwanews⁩ ⁦@TOGAANZ⁩

Bushfire smoke can harm your health, especially if you live with a lung disease! Our friends over at Centre for Safe Air have developed an a Bushfire Smoke fact sheet to help you get prepared: buff.ly/4elgtJ3

Prof Anne Holland provides an overview of the European Respiratory Society Clinical Practice Guideline on Symptom Management -including breathlessness and fatigue-for Adults with Serious Respiratory Illness

Fantastic to be at the opening of the @tsanz_thoracic Education Hub with minster @MaryAnneThomas and education hub chair @nessmcd. Looking forward to three days of learning and collaborations! #lung #lunghealth #lunglearning

#WorldLungDay advocates for the right of all people to Clean Air & Healthy Lungs. We support @FIRS_LungsFirst message to encourage communities & governments to invest in #lunghealth & combat #airpollution. For more head to our clinical resources page shorturl.at/vrQNO

A treatable traits approach to physiotherapy and nursing care in Bronchiectasis. Congrats Kirsty Watson on your 2nd PhD study @ZoeMcKeough, Tiffany Dwyer, @AnnemarieLLee1

Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype | New England Journal of Medicine nejm.org/doi/full/10.10… @ers2024

OMG! 4 years of my life will be presented at #ERSCongress2024. For those not in the room, I will live tweet the results of the ABRA trial (Acute BenRAlizumab for exacerbations). @MonaBafadhel is setting off 🧵

@SanjayResp @MonaBafadhel Congratulations Sanjay! 🥳 Excellent study!

It was great to sit at the desk with @briandkent and @asthmalondon. Something a little different for us at #ERSCongress2024 Stay tuned on the @EuroRespSoc channel for the severe asthma #cme activity!

🌏Respirology New review series issue: Treatable traits—personalised medicine for life in airway disease onlinelibrary.wiley.com/doi/toc/10.111… @nessmcd @PeterThorSoc @traitsCRE @CDharmage @HLewthwaite

Want to come along to the #TSANZ education hub and have a chance for free registration to next year’s ASM? Book now! @tsanz_thoracic

Make sure you register this week to take advantage of the early bird 🐦 rates! ♥️🫁🫁🫁🫁🫁🫁🫁🫁🫁🫁

Azithromycin effects on remission! Great paper led by Dennis Thomas for the @traitsCRE

Pre-COPD is here to stay until we find solutions-let’s work together to solve this novel paradigm

Join us for the TSANZ Education Hub in Melbourne from the 10 to 12 October, 2024. The Education Hub is a conference that consists of a carefully curated program that aims to educate and foster collaboration and dialogue that can lead to tangible improvements in lung health.

Join us for the 2024 @tsanz_thoracic Education Hub. It promises to be a great meeting with something for everyone! Early 🦜ends 26/7! tsanzeducationhub.com.au

In Current Issue! Living With #Asthma and #Vocal Cord #Dysfunction/Inducible #Laryngeal Obstruction: “I Just Can’t Get Air In” buff.ly/44WeaIL

Article Alert: Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease - Dharmage - 2024 - Respirology - Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…

Mundipharma's new agreement with #BigTobacco giant PMI's inhaler device manufacturer @VecturaGroup crosses the red line set by respiratory organisations in 2021. @tsanz_thoracic has adopted a principled but practical approach to the new agreement. Read: ow.ly/AvsB50Syq3S